Finnegan is a sponsor of the Tongxieyi webinar series. Finnegan partner Ningling Wang will review the antibody landscape, types of antibody claims, FDA Biosimilars Guidance and best practice recommendations. For more information, or to register, please see Tongxieyi’s website.
Tags
antibodies, Food and Drug Administration (FDA), District Court, Enablement (35 USC § 112), inventorship, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO)
Related Industries
Related Professionals
- Ningling Wang
- Partner
- Shanghai
- +86 21 6194 2005
